Tech Healthcare Sector

Global Medical Products Holdings

Market Cap: US$124.0

A development stage company, engages in the distribution and manufacturing services business in the Peoples Republic of China.

Whitebeard

Market Cap: US$120.0

A development stage company, engages in the research and development of medical devices with `near-patient' testing applications.

Emerging World Pharma

Market Cap: US$119.0

Invests in generic based pharmaceutical companies manufacturing within developing nations.

H-Source Holdings

Market Cap: US$117.0

A technology company, operates in the healthcare industry in the United States and internationally.

RxElite

Market Cap: US$116.0

Engages in the development, manufacture, and marketing of generic prescription drug products in specialty generic markets.

VMS Rehab Systems

Market Cap: US$111.0

Engages in generic drug and home healthcare businesses.

RVL Pharmaceuticals

Market Cap: US$111.0

Operates as a specialty pharmaceutical company.

PrimeCare Systems

Market Cap: US$110.0

PrimeCare Systems, Inc., together with its subsidiaries, engages in the creation, ownership, maintenance, and marketing of patient management systems primarily in the United States.

Green and Hill Industries

Market Cap: US$103.0

Green and Hill Industries, Inc., doing business as Ross’ Gold, distributes medical cannabis strains for various ailments and illnesses in Canada.

LifePoint

Market Cap: US$102.0

Develops, manufactures, and sells IMPACT Test System, a diagnostic testing and screening device.

OneLife Technologies

Market Cap: US$100.0

Operates as a mobile medical hardware, software, and data collection company in the United States and internationally.

Cognetivity Neurosciences

Market Cap: US$93.0

Operates as a technology company.

Alternate Health

Market Cap: US$91.0

A diversified healthcare company, provides cloud based software solutions in Canada.

GAMERICA Holdings and Acquisitions

Market Cap: US$88.0

Develops software applications in the United States.

RenovaCare

Market Cap: US$87.0

A development-stage biotech and medical device company, focuses on the research, development, and commercialization of autologous cellular therapies for use in medical and aesthetic applications.

Medicine Man Technologies

Market Cap: US$85.0

Medicine Man Technologies, Inc., doing business as Schwazze, engages in the cultivation, manufacturing, distribution, and retail sale of cannabis and cannabis related products in Colorado and New Mexico.

Alliance Growers

Market Cap: US$85.0

Engages in acquiring investments in and developing projects in the medical cannabis sector in British Columbia.

Chalice Brands

Market Cap: US$84.0

Engages in the retail, production, processing, wholesale, and distribution of cannabis products.

Cardax

Market Cap: US$82.0

A biopharmaceutical company, develops and commercializes dietary supplements for inflammatory health and pharmaceuticals for chronic diseases driven by inflammation and oxidative stress.

Yield10 Bioscience

Market Cap: US$73.0

Operates as an agricultural bioscience company that focuses on commercializing products using the Camelina oilseeds in the United States.

Indigenous Bloom Hemp

Market Cap: US$71.0

Focuses on the production of hemp products.

North Bud Farms

Market Cap: US$66.0

Through its subsidiaries, focuses on the production of pharmaceutical-grade cannabis and food grade cannabinoid infused inputs for the pharmaceutical and recreational cannabis markets in Canada.

Interpharm Holdings

Market Cap: US$66.0

Develops, manufactures, and markets generic prescription strength and over-the-counter pharmaceuticals.

Capha Pharmaceuticals

Market Cap: US$64.0

Does not have significant operations.

Sunnylife Global

Market Cap: US$63.0

Owns and operates hospitals in China.

Dermisonics

Market Cap: US$63.0

Manufactures ultrasonic transdermal drug-delivery technologies and equipment.

IMRIS

Market Cap: US$62.0

Designs, manufactures, and sells image-guided therapy solutions worldwide.

Avisa Diagnostics

Market Cap: US$59.0

Operates a clinical-stage medical device company.

Frélii

Market Cap: US$58.0

Provides personalized subscription based nutrition and wellness programs.

Panacos Pharmaceuticals

Market Cap: US$53.0

A development stage biotechnology company, engages in the discovery and development of small-molecule oral drugs designed to treat human immunodeficiency virus (HIV) and other human viral diseases.

Inyx

Market Cap: US$53.0

Through its wholly-owned subsidiaries, operates as a specialty pharmaceutical company in the United States, Canada, and Europe.

Baudax Bio

Market Cap: US$52.0

A pharmaceutical company, develops and commercializes products for hospital and other acute care related settings.

Arno Therapeutics

Market Cap: US$49.0

A biopharmaceutical company, develops products for the treatment of cancer and other life threatening diseases.

Callitas Health

Market Cap: US$45.0

Provides over the counter consumer health and wellness products in the United States and Canada.

Antigenics

Market Cap: US$45.0

A clinical-stage biopharmaceutical company, discovers, manufactures, and develops immunotherapies for cancer.

Mymetics

Market Cap: US$45.0

Engages in the research and development of vaccines for infectious and life disabling diseases in Switzerland.